New Haven, Conn. – August 29, 2017 – Alexion Pharmaceuticals, Inc. and the University of Connecticut today announced the first award made through the recently launched Alexion-UConn Rare Disease Innovation Fund.

Assistant professor of genetics and genome sciences at UConn Health, Stormy Chamberlain, Ph.D., Key Faculty in the Health Care Genetics PSM Program, received the fund’s first award. Chamberlain will conduct sponsored research related to neuro-genetic disorders.

For more details see the announcement